Cite
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment
MLA
Frederik J. H. Botha, et al. “The Early Bactericidal Activity of Rifabutin in Patients with Pulmonary Tuberculosis Measured by Sputum Viable Counts: A New Method of Drug Assessment.” Journal of Antimicrobial Chemotherapy, vol. 32, Jan. 1993, pp. 867–75. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddecef91ac694f452c918822eb292f66&authtype=sso&custid=ns315887.
APA
Frederik J. H. Botha, Bernard W. Van de Wal, Denis A. Mitchison, Peter K. Clark, D P Parkin, Frederick A. Sirgel, & Peter R. Donald. (1993). The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment. Journal of Antimicrobial Chemotherapy, 32, 867–875.
Chicago
Frederik J. H. Botha, Bernard W. Van de Wal, Denis A. Mitchison, Peter K. Clark, D P Parkin, Frederick A. Sirgel, and Peter R. Donald. 1993. “The Early Bactericidal Activity of Rifabutin in Patients with Pulmonary Tuberculosis Measured by Sputum Viable Counts: A New Method of Drug Assessment.” Journal of Antimicrobial Chemotherapy 32 (January): 867–75. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ddecef91ac694f452c918822eb292f66&authtype=sso&custid=ns315887.